Lang Matthew

General Counsel & Corp. Secy.Myovant Sciences Ltd. (MYOV) · full profile →Form 4 · filed Mar 10, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
2 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2023Disposed to issuer(D)241K0
Mar 10, 2023Disposed to issuer(D)113K241K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2023Disposed to issuer(D)170K0
Mar 10, 2023Disposed to issuer(D)152K0
Mar 10, 2023Disposed to issuer(D)90K0
Mar 10, 2023Disposed to issuer(D)111K0
Mar 10, 2023Disposed to issuer(D)87K0
Mar 10, 2023Disposed to issuer(D)220K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-017719) within minutes of acceptance. Every field above traces to the original document. Verify it directly: